NDC 70518-2912-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-2912
- Requested NDC
- 70518-2912-01
- Package NDCs from labels
- 70518-2912-1, 70518-2912-0, 70518-2912-3, 70518-2912-2, 70518-2912-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-07-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-07-30 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-2912-0 | Gabapentin | 100 in 1 BOX | TABLET | 100 | 9 | |
| 70518-2912-1 | Gabapentin | 1 in 1 POUCH | TABLET | 1 | 9 | |
| 70518-2912-2 | Gabapentin | 100 in 1 BOX | TABLET | 100 | 9 | |
| 70518-2912-3 | Gabapentin | 1 in 1 POUCH | TABLET | 1 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-2912 | GABAPENTIN TABLET [REMEDYREPACK INC.] | 6 | Current NDC, Legacy NDC, 4 package rows | 20250406_bc525ae4-9843-4038-a1b7-0d3543e2282c.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 1ead7343-ab25-41b5-af4f-f903470e1dd9 | 2025-10-10 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 781b0d62-a760-4371-8908-1f61329928a6 | 2025-10-10 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | STALLION LABORATORIES PRIVATE LIMITED | b26fd0c6-6aab-4957-8a32-cc7adb9b5fc9 | 2025-10-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | American Health Packaging | bbfdedd7-2baf-4bc6-be59-548a5cf21752 | 2025-10-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | be9a572d-e98a-41c1-83c5-859d9176dd1c | 2025-10-03 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | eaf5e41e-8ed3-404e-84e0-392bebdbc0b7 | 2025-10-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Proficient Rx LP | da8438e1-755b-4195-baa7-464f3d9ee5bd | 2025-10-01 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 8f982b95-4e84-4e0c-a543-747bc3dd7531 | 2025-09-26 | Warnings, Adverse reactions | 310433 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | d0510d04-460c-47d1-be72-0ee32c4ac640 | 2025-09-26 | Warnings, Adverse reactions | 310433 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 344d67fa-092e-4e71-b96a-25c71bfa6bb1 | 2025-09-25 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | bc1316b6-1fc4-4990-95a8-489881772876 | 2025-09-25 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Kesin Pharma Corporation | 3f2ba3d6-6086-eaf2-e063-6294a90a7642 | 2025-09-19 | Warnings, Adverse reactions | 6CW7F3G59X |
| gabapentin | GABAPENTIN | Coupler LLC | 3eeda97d-c3cd-65cd-e063-6394a90aae8b | 2025-09-16 | Warnings, Adverse reactions | 6CW7F3G59X |
| gabapentin | GABAPENTIN | Zydus Lifesciences Limited | 8c0eeefc-ef5b-49f4-8411-ddbae312ed05 | 2025-09-15 | 6CW7F3G59X | |
| GABAPENTIN | GABAPENTIN | MARKSANS PHARMA LIMITED | 98bb408d-c402-4da6-8f9d-5de4833dedc4 | 2025-09-12 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Epic Pharma, LLC | d592d828-8df1-480d-b179-bb9260a9c824 | 2025-09-12 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Zydus Pharmaceuticals USA Inc. | 310ce005-5a24-489a-b23c-d42ab6a3bfed | 2025-09-08 | Warnings, Adverse reactions | 310433 310434 6CW7F3G59X |
| gabapentin | GABAPENTIN | Zydus Pharmaceuticals USA Inc. | 3cfd04ab-e421-441f-a10e-e4dd1412974d | 2025-09-05 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Rising Pharma Holdings, Inc. | b1a9808d-31a5-4b63-afd0-d96d5a0ad7a1 | 2025-09-03 | Warnings, Adverse reactions | 310433 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Mullan Pharmaceutical Inc. | 74474aa4-4859-42d2-92d8-f23f18b34e04 | 2025-08-21 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.